Prevalence of prediabetes and undiagnosed type 2 diabetes in France : Results from the national survey ESTEBAN, 2014-2016
Copyright © 2020. Published by Elsevier B.V..
AIM: To assess the prevalence of prediabetes, undiagnosed diabetes and diagnosed diabetes in France, among adults between 2014 and 2016 using data from the nationwide Esteban survey.
METHODS: National cross-sectional study conducted between 2014 and 2016 in metropolitan France. Individuals aged 18 to 74 were recruited with a 3-stage geographic sampling. They completed two face-to-face interviews, filled in a self-administered questionnaire and underwent a medical examination with the collection of biological samples. Their data were linked to the National Health Data System to identify anti-diabetic drugs reimbursement. Prediabetes and undiagnosed diabetes were defined as no diagnosis of diabetes and 6.1 mmol/l ≤ Fasting Plasma Glucose (FPG) < 7.0 mmol/l for prediabetes and FPG ≥ 7.0 mmol/l for undiagnosed diabetes. Non-pharmacologically treated diabetes and pharmacologically treated diabetes were defined as self-reported diabetes without or with self-reported or reimbursed antidiabetic medication, respectively. Estimated prevalence were weighted to take into account survey design and non-response.
RESULTS: The ESTEBAN survey recruited 3476 adults, 2270 were included in this analysis. The weighted prevalence was 1.7% [1.1 - 2.4] for undiagnosed diabetes (men: 2.7%, women; 0.9%), 9.9% [8.3 - 11.5] for prediabetes (men: 13.2%, women: 7.0%), 5.7% [4.3 - 7.1] for diagnosed diabetes. Among the diagnosed cases, 79% were pharmacologically treated. Among all diabetes cases, 23% were undiagnosed.
CONCLUSION: The prevalence of undiagnosed diabetes and prediabetes is increasing in France. Our results highlight the need to increase primary prevention and reinforce secondary prevention of diabetes.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:165 |
---|---|
Enthalten in: |
Diabetes research and clinical practice - 165(2020) vom: 20. Juli, Seite 108252 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lailler, Grégory [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 17.09.2020 Date Revised 17.09.2020 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.diabres.2020.108252 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM311054854 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM311054854 | ||
003 | DE-627 | ||
005 | 20231225141429.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.diabres.2020.108252 |2 doi | |
028 | 5 | 2 | |a pubmed24n1036.xml |
035 | |a (DE-627)NLM311054854 | ||
035 | |a (NLM)32526264 | ||
035 | |a (PII)S0168-8227(20)30502-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lailler, Grégory |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prevalence of prediabetes and undiagnosed type 2 diabetes in France |b Results from the national survey ESTEBAN, 2014-2016 |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.09.2020 | ||
500 | |a Date Revised 17.09.2020 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020. Published by Elsevier B.V. | ||
520 | |a AIM: To assess the prevalence of prediabetes, undiagnosed diabetes and diagnosed diabetes in France, among adults between 2014 and 2016 using data from the nationwide Esteban survey | ||
520 | |a METHODS: National cross-sectional study conducted between 2014 and 2016 in metropolitan France. Individuals aged 18 to 74 were recruited with a 3-stage geographic sampling. They completed two face-to-face interviews, filled in a self-administered questionnaire and underwent a medical examination with the collection of biological samples. Their data were linked to the National Health Data System to identify anti-diabetic drugs reimbursement. Prediabetes and undiagnosed diabetes were defined as no diagnosis of diabetes and 6.1 mmol/l ≤ Fasting Plasma Glucose (FPG) < 7.0 mmol/l for prediabetes and FPG ≥ 7.0 mmol/l for undiagnosed diabetes. Non-pharmacologically treated diabetes and pharmacologically treated diabetes were defined as self-reported diabetes without or with self-reported or reimbursed antidiabetic medication, respectively. Estimated prevalence were weighted to take into account survey design and non-response | ||
520 | |a RESULTS: The ESTEBAN survey recruited 3476 adults, 2270 were included in this analysis. The weighted prevalence was 1.7% [1.1 - 2.4] for undiagnosed diabetes (men: 2.7%, women; 0.9%), 9.9% [8.3 - 11.5] for prediabetes (men: 13.2%, women: 7.0%), 5.7% [4.3 - 7.1] for diagnosed diabetes. Among the diagnosed cases, 79% were pharmacologically treated. Among all diabetes cases, 23% were undiagnosed | ||
520 | |a CONCLUSION: The prevalence of undiagnosed diabetes and prediabetes is increasing in France. Our results highlight the need to increase primary prevention and reinforce secondary prevention of diabetes | ||
650 | 4 | |a Historical Article | |
650 | 4 | |a Journal Article | |
700 | 1 | |a Piffaretti, Clara |e verfasserin |4 aut | |
700 | 1 | |a Fuentes, Sonsoles |e verfasserin |4 aut | |
700 | 1 | |a Nabe, Hadja Djessira |e verfasserin |4 aut | |
700 | 1 | |a Oleko, Amivi |e verfasserin |4 aut | |
700 | 1 | |a Cosson, Emmanuel |e verfasserin |4 aut | |
700 | 1 | |a Fosse-Edorh, Sandrine |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diabetes research and clinical practice |d 1993 |g 165(2020) vom: 20. Juli, Seite 108252 |w (DE-627)NLM01260335X |x 1872-8227 |7 nnns |
773 | 1 | 8 | |g volume:165 |g year:2020 |g day:20 |g month:07 |g pages:108252 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.diabres.2020.108252 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 165 |j 2020 |b 20 |c 07 |h 108252 |